Date | Intervention | Expected impact on | |
MRSA | MSSA | ||
Haemodialysis and renal unit | |||
Feb 1996 | Renal dialysis patients screened for MRSA every 3 months and all MRSA-positive renal dialysis patients decontaminated | Reduce | |
Jun 2000 | Decontamination of all patients with Tessio lines (regardless of MRSA/MSSA status) | Reduce | Reduce |
Aug 2005 | Routine decontamination for MRSA-positive renal dialysis patients stopped | Increase | |
Sep 2006 | Intensive audits assessing compliance with line insertion and after care in renal (and intensive care) units | Reduce | Reduce |
Jul 2007 | Waiting time for fistula formation for renal dialysis changed from a 6-month wait to a 4-week wait | Reduce | Reduce |
Intensive care unit | |||
Feb 1996 | Intensive therapy unit patients screened for MRSA at admission (risk-based) | Reduce | |
Jun 2002 | Antimicrobial impregnated lines introduced | Reduce | Reduce |
Sep 2006 | Intensive audits assessing compliance with line insertion and after care in intensive care (and renal) unit | Reduce | Reduce |
Sep 2007 | Central line insertion pack and minimum standards implemented in intensive care and theatres | Reduce | Reduce |
Aug 2008 | Decontamination of all patients in intensive therapy unit (regardless of MRSA/MSSA status) | Reduce | Reduce |
Hospital-wide | |||
Mar 1997 | Risk-based MRSA screening | Reduce | |
Jun 2006 | Intensive hand-hygiene training and audit | Reduce | Reduce |
Nov 2006 | Intensive audit programme for line and urinary catheter insertion and aftercare and care bundle for ventilated patients | Reduce | Reduce |
Nov 2006 | Root-cause analysis of all MRSA bacteraemia | Reduce | |
Sep 2007 | Clean your hands alcohol hand gel introduction | Reduce | Reduce |
Feb 2008 | Root cause analysis of all line related S aureus bacteraemia | Reduce | Reduce |
Sep 2008 | Decontamination of all patients admitted to general medicine and gerontology (regardless of MRSA/MSSA status) using daily Triclosan wash for first 5 days | Reduce | Reduce |
Mar 2009 | MRSA screening of elective admissions and decontamination of patients who are MRSA-positive with chlorhexidine wash and chlorhexidine/neomycin (Naseptin) nasal cream for 5 days | Reduce | |
Apr 2009 | 24 h decontamination for patients undergoing high-risk surgery (regardless of MRSA/MSSA status) with chlorhexidine wash and Naseptin nasal cream; chlorhexidine mouthwash added if admitted to intensive therapy unit | Reduce | Reduce |
Department of health and other national targets, campaigns and reports | |||
Dec 2003 | Winning ways report (DH) | ||
Jul 2004 | Towards cleaner hospitals (DH) | ||
Sep 2004 | Clean your hands (NPSA) | ||
Nov 2004 | MRSA reduction target (DH) | ||
Jun 2005 | Saving Lives Programme (DH) | ||
Oct 2006 | Health Act 2006 (DH) | ||
Jun 2007 | Clean safe care: reducing MRSA and other healthcare-associated interventions (DH) | ||
Apr 2009 | National elective screening (DH) | ||
National audit office reports | |||
Feb 2000 | NAO report | ||
Jul 2004 | NAO report | ||
Jun 2009 | NAO report |
DH, Department of Health; MRSA, meticillin-resistant Staphylococcus aureus; MSSA, meticillin-sensitive Staphylococcus aureus; NAO, National Audit Office.